ClinVar Miner

Submissions for variant NM_207352.4(CYP4V2):c.367A>G (p.Met123Val)

gnomAD frequency: 0.00021  dbSNP: rs149684063
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 10
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Soonchunhyang University Bucheon Hospital, Soonchunhyang University Medical Center RCV000032541 SCV000267285 uncertain significance Bietti crystalline corneoretinal dystrophy 2016-03-18 criteria provided, single submitter reference population
Illumina Laboratory Services, Illumina RCV000032541 SCV000448827 uncertain significance Bietti crystalline corneoretinal dystrophy 2017-04-27 criteria provided, single submitter clinical testing The CYP4V2 c.367A>G (p.Met123Val) missense variant has been reported in a compound heterozygous state in one individual with Bietti crystalline dystrophy (Li et al. 2004). The p.Met123Val variant was absent from 100 controls but is reported at a frequency of 0.00496 in the East Asian population of the 1000 Genomes Project. The evidence for this variant is limited. The p.Met123Val variant is therefore classified as a variant of unknown significance but suspicious for pathogenicity for Bietti crystalline dystrophy. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.
Illumina Laboratory Services, Illumina RCV000260520 SCV000448828 uncertain significance Corneal dystrophy 2017-04-27 criteria provided, single submitter clinical testing This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance.
Blueprint Genetics RCV001074793 SCV001240390 uncertain significance Retinal dystrophy 2019-07-03 criteria provided, single submitter clinical testing
CeGaT Center for Human Genetics Tuebingen RCV000132718 SCV001249265 uncertain significance not provided 2019-08-01 criteria provided, single submitter clinical testing
Invitae RCV000132718 SCV001733227 benign not provided 2024-01-18 criteria provided, single submitter clinical testing
3billion RCV000032541 SCV002572707 uncertain significance Bietti crystalline corneoretinal dystrophy 2022-09-01 criteria provided, single submitter clinical testing The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.074%). Same nucleotide change resulting in same amino acid change has been previously reported to be associated with CYP4V2-related disorder (PMID: 15042513). However, the evidence of pathogenicity is insufficient at this time. Therefore, this variant is classified as uncertain significance according to the recommendation of ACMG/AMP guideline.
Dept Of Ophthalmology, Nagoya University RCV001074793 SCV004706578 likely pathogenic Retinal dystrophy 2023-10-01 criteria provided, single submitter research
GeneReviews RCV000032541 SCV000056208 pathologic Bietti crystalline corneoretinal dystrophy 2012-04-12 no assertion criteria provided curation Converted during submission to Pathogenic.
Department of Ophthalmology and Visual Sciences Kyoto University RCV000132718 SCV000172672 probable-non-pathogenic not provided no assertion criteria provided not provided Converted during submission to Likely benign.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.